REAL-WORLD EFFICACY OF EMICIZUMAB PROPHYLAXIS IN PATIENTS WITH SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: A REPORT FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION

被引：0
|
作者：
Wall, C. [1 ]
Xiang, H. [2 ]
Palmer, B. [2 ]
Collins, P. W. [3 ]
Stephensen, D. [4 ]
Scott, M. [5 ]
Chalmers, E. [6 ]
Chowdary, P. [7 ]
Hall, G. W. [8 ]
Liesner, R. [9 ]
Hart, D. P. [10 ]
Shapiro, S. [11 ]
Talks, K. [12 ]
Fletcher, S. [13 ]
Hay, C. R. [1 ]
机构：
[1] Manchester Royal Infirm, Manchester, Lancs, England
[2] UK Natl Haemophilia Database, Manchester, Lancs, England
[3] Cardiff Univ, Sch Med, Cardiff, Wales
[4] Kent & Canterbury Hosp, Kent Haemophilia Ctr, Canterbury, Kent, England
[5] Manchester Royal Infirm, Manchester Adults Haemophilia Ctr, Manchester, Lancs, England
[6] Royal Hosp Sick Children, Glasgow, Lanark, Scotland
[7] Royal Free Hosp, KD Haemophilia & Thrombosis Ctr, London, England
[8] John Radcliffe Hosp, Childrens Haematol & Oncol, Oxford, England
[9] Great Ormond St Hosp Sick Children, Great Ormond St Haemophilia Ctr, London, England
[10] Barts & London Queen Marys Sch Med & Dent, Royal London Haemophilia Ctr, London, England
[11] Oxford Univ Hosp NHS Fdn Trust, NIHR Oxford Biomed Res Ctr, Oxford, England
[12] Royal Victoria Infirm, Newcastle Haemophilia Ctr, Newcastle Upon Tyne, Tyne & Wear, England
[13] Oxford Haemophilia & Thrombosis Ctr, Oxford, England
来源：
HAEMOPHILIA | 2021年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
ABS176
引用
收藏
页码：116 / 116
页数：1
相关论文
共 50 条
  • [1] EMICIZUMAB PROPHYLAXIS IN SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: OUTCOME AND INDICATIONS. FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Hay, C. R. M.
    Wall, C.
    Xiang, H.
    Palmer, B.
    Chowdary, P.
    Collins, P.
    Fletcher, S.
    Hall, G. W.
    Mathias, M.
    Percy, C.
    Sartain, P.
    Susan, S.
    Stephensen, D.
    Talks, K.
    HAEMOPHILIA, 2022, 28 : 50 - 51
  • [2] EMICIZUMAB PROPHYLAXIS IN SEVERE HAEMOPHILIA A WITHOUT INHIBITORS: OUTCOME AND INDICATIONS. FROM THE UK HAEMOPHILIA CENTRE DOCTORS' ORGANISATION
    Hay, C.
    Wall, C.
    Xiang, H.
    Palmer, B.
    Chowdary, P.
    Collins, P.
    Fletcher, S.
    Mathias, M.
    Percy, C.
    Sartain, P.
    Shapiro, S.
    Stephensen, D.
    Talks, K.
    HAEMOPHILIA, 2023, 29 : 78 - 79
  • [3] REAL-WORLD SAFETY AND EFFICACY OF EMICIZUMAB IN HAEMOPHILIA A WITH INHIBITORS IN THE UK
    Wall, C.
    Hall, G.
    Scott, M.
    Collins, P. W.
    Maclean, R.
    Xiang, H.
    Hay, C. R.
    Hart, D. P.
    Anderson, J.
    Dolan, G.
    Symington, E.
    HAEMOPHILIA, 2020, 26 : 64 - 65
  • [4] Emicizumab prophylaxis in haemophilia A with inhibitors: Three years follow-up from the UK Haemophilia Centre Doctors' Organisation (UKHCDO)
    Wall, Caroline
    Xiang, Hua
    Palmer, Ben
    Chalmers, Elizabeth
    Chowdary, Pratima
    Collins, Peter W.
    Fletcher, Simon
    Hall, Georgina W.
    Hart, Daniel P.
    Mathias, Mary
    Sartain, Paul
    Shapiro, Susan
    Stephensen, David
    Talks, Kate
    Hay, Charles R. M.
    HAEMOPHILIA, 2023, 29 (03) : 743 - 752
  • [5] EMICIZUMAB PROPHYLAXIS IN HAEMOPHILIA A WITH AND WITHOUT INHIBITORS: REAL-WORLD DATA FROM SLOVENIA
    Rener, K.
    Doma, S. Anzej
    Kotnik, B. Faganel
    Kitanovski, L.
    Fink, M.
    Zupan, I. Preloznik
    HAEMOPHILIA, 2021, 27 : 70 - 70
  • [6] Real-world experience on the tolerability and safety of emicizumab prophylaxis in paediatric patients with severe haemophilia A with and without FVIII inhibitors
    Hassan, Eman
    Jonathan, Lancashire
    Jayashree, Motwani
    HAEMOPHILIA, 2021, 27 (06) : E698 - E703
  • [7] EMICIZUMAB PROPHYLAXIS IN ADULT AND PAEDIATRIC HAEMOPHILIA A PATIENTS WITHOUT INHIBITORS: A SINGLE CENTRE REAL WORLD EXPERIENCE
    Catalano, A.
    Di Gregorio, P.
    Di Cocco, M. L.
    Malizia, R.
    Paolini, F.
    Verna, S.
    HAEMOPHILIA, 2021, 27 : 70 - 70
  • [8] Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors
    Ebbert, Patrick T.
    Xavier, Frederico
    Seaman, Craig D.
    Ragni, Margaret V.
    HAEMOPHILIA, 2020, 26 (01) : 41 - 46
  • [9] Real-world experience with the use of emicizumab in paediatric haemophilia A patients with and without inhibitors
    Lam, Joyce Ching Mei
    Lim, Chiew Ying
    Kadir, Nur Insyirah Abdul
    HAEMOPHILIA, 2022, 28 : 50 - 51
  • [10] Real-world data of prophylaxis with emicizumab in children and adolescents with severe haemophilia: A single centre experience
    Michalopoulou, A.
    Dettoraki, A.
    Karelioti, H.
    Thymianou, S.
    Papageorgiou, N.
    Stamati, I.
    Saslis, S.
    Kapsimali, Z.
    Pergantou, H.
    HAEMOPHILIA, 2024, 30 : 61 - 61
12345